The Effect of Dual Anti-platelet Treatment on Upper Gastrointestinal Bleeding after Percutaneous Coronary Intervention
10.3969/j.issn.0253-9896.2014.03.018
- VernacularTitle:双联抗血小板聚集药物对PCI患者上消化道出血的影响
- Author:
Xue FENG
;
Zhiguang ZHANG
;
Man LI
- Publication Type:Journal Article
- Keywords:
platelet aggregation inhibitors;
gastrointestinal hemorrhage;
angioplasty,transluminal,percutaneous coronary;
proton pump inhibitors
- From:
Tianjin Medical Journal
2014;(3):251-253
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the risk factors of dual anti-platelet treatment in upper gastrointestinal hemor-rhage after percutaneous coronary intervention (PCI). Methods Clinical data of 2004 PCI patients with dual anti-platelet treatment were collected,including gender,age,body mass index (BMI),history of drug therapy, history of digestive disease, history of smoking and drinking,history of hypertension,history of diabetes,history of cerebrovascular disease and history of combined treatment with a proton pump inhibitor (PPI). The different characteristics of gastrointestinal bleeding were com-pared. The risk factors of upper gastrointestinal bleeding were analyzed. Results The risk factors for PCI patients with up-per gastrointestinal bleeding were age>65 years of old, history of smoking, history of hypertension,abnormal platelet count, creatinine and hemoglobin. The combined treatment with a proton pump inhibitor was a protective factor associated with gas-trointestinal bleeding. Conclusion We should pay attention to the upper gastrointestinal bleeding induced by dual anti-platelet treatment, and take appropriate measures to reduce the incidence of gastrointestinal bleeding in PCI patients.
